Medindia LOGIN REGISTER
Medindia

High Dosage of Zinc Acetate Lozenges Cut Common Cold Symptoms

by Bidita Debnath on Mar 17 2015 10:53 PM

High Dosage of Zinc Acetate Lozenges Cut Common Cold Symptoms
Why suffer from common cold for longer when its symptoms can be treated with a high dose of zinc acetate lozenges? That’s right! A new study has revealed that if you take drug in high doses, it can reduce the duration of common cold by 42%.
Zinc Acetate Lozenge formula was formulated to reduce the duration of common cold by a week. This is the only product in the world that reduces the duration and severity of all common cold symptoms by half in three independent, non-company, double-blind, clinical trials published in many peer-reviewed medical journals in the history of common cold research.

When zinc acetate lozenges dissolve in the mouth, zinc ions are released into the saliva of the pharyngeal region where the levels are consequently high. Therefore the effects of zinc lozenges might be greatest on symptoms of the pharyngeal region such as sore throat and less on nasal symptoms.

According to the calculations by researchers Harri Hemila from Helsinki, Finland and Elizabeth Chalker from Sydney, Australia, high dose zinc acetate lozenges shortened the duration of nasal discharge by 34%, nasal congestion by 37%, sneezing by 22%, scratchy throat by 33%, sore throat by 18%, hoarseness by 43% and cough by 46%.

Furthermore, they found strong evidence that zinc lozenges also shortened the duration of muscle ache by 54%. On the other hand, there was no evidence of zinc effect on the duration of headache and fever. However, the latter two symptoms were infrequent in the three studies and therefore no definite conclusions can be drawn on headache and fever.

Adverse effects of zinc were minor in the study and therefore, researchers conclude from their research that zinc acetate lozenges releasing zinc ions at doses of about 80 mg/day may be a useful treatment for the common cold, started within 24 hours, for a time period of less than two weeks.

The study is published in BMC Family Practice.

Advertisement
Source-ANI


Advertisement